BioCentury | Apr 19, 2019
Targets & Mechanisms

The next wave in neurodegeneration expands beyond neurons

...Therapeutics Inc. (NASDAQ:VTVT) Azeliragon AD in patients with Type II diabetes Ph II/III (A) RAGE Medifron DBT Co. Ltd....
Items per page:
1 - 1 of 1
BioCentury | Apr 19, 2019
Targets & Mechanisms

The next wave in neurodegeneration expands beyond neurons

...Therapeutics Inc. (NASDAQ:VTVT) Azeliragon AD in patients with Type II diabetes Ph II/III (A) RAGE Medifron DBT Co. Ltd....
Items per page:
1 - 1 of 1